Analyst Ratings for Pluristem Therapeutics (PSTI)

PSTI Rating Summary

PSTI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PSTI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $3.75 (+3%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/16/2013 Maxim Group Upgrade Buy
(Hold)
N/A
(N/A)
3.22 3.64 13.04% Details
5/31/2013 MLV & Co. New Coverage Buy
(N/A)
4.50
(N/A)
3.14 3.64 15.92% Details